ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2393

Demographic Differences in Trends of Systemic Lupus Erythematosus In-hospital Patient Outcomes

Joan Morny1, Abdultawab Shaka2, Terrylyna Baffoe-Bonnie3 and Hafeez Shaka4, 1Piedmont Athens Regional Medical Center, athens, GA, 2Windor University School of Medicine, Saint Kitts and Nevis, U.S. Virgin Islands, 3Medstar Health Union Memorial Hospital, Baltimore, MD, 4Stroger Jr Hospital, Chicago, IL

Meeting: ACR Convergence 2024

Keywords: Mortality, race/ethnicity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The care of patients with Systemic Lupus Erythematosus (SLE) is challenging, and with the emergency of newer disease modifying medications, clinical outcomes in these patients may be positively affected. We conducted a trend analysis of in-hospital outcomes of patients admitted for SLE within a 10-year period, with a specific emphasis on racial differences in mortality.

Methods: Using 2010 to 2019 National Inpatient Sample data, we identified SLE related admissions based on International Classification of Diseases, Ninth and Tenth Edition, Clinical Modification codes. Primary outcomes of interest were in-hospital mortality, length of hospital stay, and total hospital charges trends over the last 10 years in all patients admitted with a principal diagnosis of SLE. Secondary outcome of interest was in-hospital mortality as it pertains to race. Weighted national estimates of admissions were used to assess trends over time using logistic regression. A p-value of < 0.05 was considered as statistically significant.

Results: We identified a total number of 111,192 admissions between 2010 and 2019 with a primary diagnosis of SLE. A decrease in SLE admissions was observed over the period, from 13,283.57/year [11207.94 – 15359.2] to 10025/year [9197.68 – 10852.3] over the last 10 years. Mean (SD) admission age has increased from 37.4 (0.5) to 38.3 (0.4) years, coefficient 0.01 [ -0.08 – 0.100]. p=0.824. The proportion of admitted female patients slightly reduced from 88.7% to 87.2%, p=0.311. There was a downward trend in in-hospital mortality of 0.2% from 1.3% to 1.1%, p=0.288. Mean (SD) length of hospital stay (LOS) slightly reduced from 6.5 (0.2) days to 6.4 (0.2) days and mean (SD) total hospital charge increased from $55,950.2 ($3273) to $72,445.9 ($3023.9). With increasing years, the odds of in-hospital mortality were AOR 1.01 (CI: 0.97 – 1.06) p=0.664. As compared to age 18 – 44 years, those 45 – 64 years of age, ≥ 65 years of age were increasingly more likely to experience in-hospital mortality AOR 2.09 (CI: 1.58 – 2.78), p< 0.001 and AOR 4.65 (CI: 3.23 – 6.69), p< 0.001 respectively. Females as compared to males were not more likely to experience in-hospital mortality AOR 0.82 (CI: 0.58 – 1.17), p=0.276. As compared to non-Hispanic whites, non-Hispanic blacks/African Americans AOR 1.13 (CI: 0.82 – 1.56), p=0.466, Hispanics AOR 1.05 (CI: 0.70 – 1.59), p=0.814), and Non-Hispanic Others AOR 1.54 (CI:1.04 – 2.28), p=0.032.  

Conclusion: Over the last 10 years, there has been a trend towards an increase in SLE-related admissions, with an associated increase in the age of the admitted patient population, and a downward trend in the proportion of admitted female patients. LOS and mortality show a downward trend while mean hospital charges as increased. The observed trends are likely due to an increase in SLE-related admission is likely related to an improvement in the diagnosis of SLE over the years while the increase trend in costs may be related to the overall increase in the cost of health care over the years. Increasing age and some minority race is associated with a higher probability of in-hospital mortality. This highlights the existing disparity in the care of patients with SLE


Disclosures: J. Morny: None; A. Shaka: None; T. Baffoe-Bonnie: None; H. Shaka: None.

To cite this abstract in AMA style:

Morny J, Shaka A, Baffoe-Bonnie T, Shaka H. Demographic Differences in Trends of Systemic Lupus Erythematosus In-hospital Patient Outcomes [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/demographic-differences-in-trends-of-systemic-lupus-erythematosus-in-hospital-patient-outcomes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/demographic-differences-in-trends-of-systemic-lupus-erythematosus-in-hospital-patient-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology